The Annals Summaries of the Latest Medical Research!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 27 June 2006, www.theannals.com, DOI 10.1345/aph.1H334.
The Annals of Pharmacotherapy: Vol. 40, No. 7, pp. 1441-1444. DOI 10.1345/aph.1H334
© 2006 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in The Annals
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karpa, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karpa, K. D.

Pharmacist Critique Was Ill-Informed

Kelly Dowhower Karpa, PhD BS Pharm

Assistant Professor, Department of Pharmacology, College of Medicine, Pennsylvania State University, 500 University Dr., Mailcode H078, Hershey, PA 17033-2360, fax 717/533-2006, kjd136{at}psu.edu

Reprints: Dr. Karpa


    Abstract
 Top
 Abstract
 Exercising a Professional Right...
 Pharmacists in Clinical Practice
 References
 
Pharmacists' ability to exercise "professional right of conscience" in dispensing emergency contraception, as well as the professionalism of pharmacists, has fallen under attack recently by the media, by state governments, and even by other healthcare professionals in published commentaries. This editorial discusses the controversy surrounding emergency contraceptives, the right of pharmacists to refuse to fill prescriptions that they consider morally objectionable, and the responsibility of pharmacists to provide medications in a timely and professional manner. The professionalism of pharmacy is also examined in light of the expanded scope of practice in which pharmacists increasingly find themselves practicing.

Key Words: emergency contraception, professional right of conscience

Published Online, June 27, 2006. www.theannals.com, DOI 10.1345/aph.1H334


It was with great distress that I read the recent commentary in Obstetrics and Gynecology authored by Wall and Brown, entitled "Refusals by Pharmacists to Dispense Emergency Contraception: A Critique."1 Written by an obstetrician/gynecologist from Washington University School of Medicine in St. Louis and an associate faculty member from Michigan State University's Center for Ethics and Humanities, the article's intent was to argue that pharmacists should not be permitted to declare a "professional right of conscience" and should not be allowed to decline to fill prescriptions based on personal beliefs, such as in situations in which a medication is morally or ethically objectionable to the dispensing pharmacist.

In their commentary, Wall and Brown appear to have a personal axe to grind. Rather than argue their viewpoint based upon facts that can be substantiated and cited in current literature, they chose instead to berate pharmacists everywhere and to create a fictitious case scenario upon which they built their platform.

In stark contrast to their original intent, Wall and Brown successfully demonstrated their lack of knowledge of modern-day pharmacy practice and the positions of professional pharmacy and medical organizations, including the Academy of Managed Care Pharmacy, the American College of Clinical Pharmacy, the American Pharmacists Association, the American Society of Health-System Pharmacists, and the American Medical Association (AMA). Frankly, it is surprising that the American College of Obstetrics and Gynecologists (ACOG) chose to publish Wall and Brown's commentary, given that it is fraught with accusations, inconsistencies, and false information.

Although numerous holes exist in their arguments against pharmacists' professional right of conscience, the disparaging remarks and incorrect depiction of contemporary pharmacists' roles in the healthcare system are the most disturbing parts of their article.

The coauthors state in no uncertain terms that pharmacists are incomplete, unlearned professionals who have more in common with community retailers than with other "traditional learned professions." Furthermore, according to Wall and Brown, a pharmacist's job entails "exercising only technical supervision over dispensation of medications."


    Exercising a Professional Right of Conscience
 Top
 Abstract
 Exercising a Professional Right...
 Pharmacists in Clinical Practice
 References
 
As a scientist, professor, and pharmacist, I am fully aware that ACOG's official position statement indicates that pregnancy begins with the implantation of a blastocyst. Nonetheless, my personal belief, and that of many others, is that a new life is created the moment 2 unique sets of DNA are comingled. I am of the opinion that life— the ability for a new human being to be born into the world to cry, to run, to sing, to play, to dance—occurs at the moment of conception, rather than a few days later when the blastocyst implants into the endometrial wall.

For myself and others who share this belief, use of emergency contraceptives raises important ethical questions and concerns. Wall and Brown allege that pharmacists with moral objections to emergency contraceptives are misinformed or promoting personal moral or political agendas; however, these objections are also scientifically based, as it is not clear how emergency contraceptives prevent pregnancy. Furthermore, the efficacy of emergency contraception appears to vary, depending upon the timing of intercourse, the timing of ovulation, and the timing of emergency contraception administration. Thus, the precise mechanism of emergency contraception may vary from one individual or circumstance to another.

While Wall and Brown would lead readers to believe that emergency contraception's only mechanism of action is the prevention of ovulation, I believe that the available data suggest otherwise. In fact, emergency contraceptives could not be as effective as they have proven to be if they worked only when taken before ovulation. Additional potential mechanisms by which emergency contraceptives may work include: thickening of cervical mucus, alterations in sperm penetration or transport, or interference with fertilization, follicular growth, corpus luteum development, and/or implantation.2-9

Given the seeming ambiguity surrounding emergency contraception's mechanism of action, it is no surprise that some physicians choose not to prescribe these products and some pharmacists opt not to dispense the drugs for personal conscience reasons. It seems that, at the very least, emergency contraceptives may interfere with the potential viability of a fertilized egg, and some healthcare professionals object to aiding and abetting such an action.

Rather than embrace our differences and simply agree to disagree about moral and ethical dilemmas, Wall and Brown assert, "Pharmacists who refuse to fill legitimate prescriptions for medications because of their personal values and opinions should be held accountable for their actions. Such violations should be reportable to state boards of pharmacy, and pharmacists who engage in such activities should be liable for sanctions including the loss of their licenses, and employers should be able to use such behavior by pharmacists as legitimate grounds for terminating their employment."

To that, I ask, why the double standard? Physicians are not forced to participate in or perform actions that they find morally objectionable. Why should pharmacists be held to a different set of rules? Not only do pharmacy organizations support pharmacists' right of conscience, but the AMA does as well. Indeed, the AMA affirms in its policy and position statements that "no physician or other professional personnel shall be required to perform an act violative of personally held moral principles." Physicians are not required to provide medical services to which they are morally opposed; therefore, neither should pharmacists be held to "required or fired" standards.

Instead, a priori communication and safeguards should be established by pharmacists and physicians to avoid these types of conflicts. Pharmacists should be permitted to refrain from participating in activities that are personally objectionable; however, pharmacists' choice to do so should not become a barrier to providing legitimately and accurately prescribed medications to patients in a timely fashion.

Potential conflicts can be avoided when (1) prescribers direct patients to pharmacies that are willing to stock and dispense certain medications, such as emergency contraceptives, (2) the shifts of pharmacy staff members overlap, allowing one pharmacist on duty to complete prescriptions that another pharmacist finds morally objectionable, (3) pharmacists provide immediate referral to alternative dispensing pharmacies, or, as the AMA's own directive states, (4) physicians dispense "medication to their own patients when there is no pharmacist within a 30 mile radius who is able and willing to dispense that medication." Notice that, according to the AMA's own directive (adopted in response to and in support of the pharmacists' professional right of conscience), prior planning is also the responsibility of the physician.

Wall and Brown assert that pharmacists have a "duty to fill," period. According to the authors, "to refuse to fill legitimate prescriptions for purported `reasons of conscience' introduces an unjust and unacceptable level of arbitrariness into the health care system." They assert that allowing pharmacists to exercise a professional right of conscience is synonymous with allowing pharmacists to hijack the healthcare system.

If a pharmacist's role were merely to dispense lawfully prescribed medications, then automation could take over. However, pharmacists are the most accessible members of the healthcare team and, in rural communities, they may be the only accessible healthcare provider. The role of pharmacists is more than counting pills and putting them into a prescription vial; a pharmacist's role is to interface and collaborate with physicians and patients to improve healthcare outcomes—a role to which Wall and Brown seem to be completely oblivious.


    Pharmacists in Clinical Practice
 Top
 Abstract
 Exercising a Professional Right...
 Pharmacists in Clinical Practice
 References
 
Pharmacists are increasingly engaged in activities formerly performed only by physicians. In more than 40 states, pharmacists are authorized to adjust medication therapy under protocol. In 44 states, pharmacists may immunize patients. In 9 states, pharmacists have legal authority to prescribe and dispense certain classes of prescription drugs (including emergency contraceptives). Furthermore, in all 50 states, it is not only legal but required that pharmacists counsel patients about appropriate use of their medications when new drugs are dispensed.

Pharmacists have also been given authority to bill Medicare for cognitive medication therapeutic management services that are provided to Medicare Part D beneficiaries. In fact, the AMA developed pharmacist-specific current procedural terminology codes to be utilized for this purpose. Therefore, Wall and Brown's assertion that "pharmacists exercise only technical supervision over the dispensation of medications that are prescribed by physicians" is simply false and demonstrates how grossly uninformed the authors are about the expanding roles of pharmacists.

Despite their apparent disdain for pharmacists, Wall and Brown contradict their own statements when they first allege that pharmacists are only retailers, having little in common with members of the traditional learned professionals (such as physicians), but subsequently state that they "do not expect pharmacists to fill prescriptions that contain obvious dosing errors or that pose a dangerous risk of interacting with other drugs." How is it that unlearned, incomplete professionals could be held responsible for catching physician mistakes and errors in clinical judgment? Unless, of course, pharmacists are not unlearned, as Wall and Brown argue, but rather are the acknowledged experts on the action of drugs. Is it possible, then, that pharmacists merely exercise technical supervision over dispensation of medication? I think not.

Unlike Wall and Brown's assertion that a patient's interaction with a pharmacist is one of a retailer-customer interaction, as opposed to an interaction between a healthcare professional and patient, inpatient clinical pharmacists have worked directly with physicians and patients for decades, providing services that are not associated with dispensation of drugs. Pharmacists have been recognized in 2 Institute of Medicine reports as essential resources for the safe use of medications.10,11 Pharmacist participation on hospital rounds has been associated with improved medication safety, and significant importance has been placed upon the collaboration between pharmacists, physicians, and patients.

Even in the outpatient setting, patients pay visits to pharmacists because pharmacists can truly provide them and their physician with a third-party objective analysis of drug therapy problems and potential solutions. Increasingly, a new breed of consulting pharmacists is offering patient consultations via provision of drug-disease management services. Patients schedule appointments with these consulting pharmacists, not because they are retailers (in many cases, consulting pharmacists have nothing to sell), but rather to improve their health through education and appropriate medication use. When these consulting pharmacists schedule patient appointments, a comprehensive medical history is obtained and laboratory results are analyzed. Many pharmacists also perform limited physical assessments including blood pressure monitoring and diabetic foot examinations. As pharmacists actively engaged in patient consulting services know, it takes only one successful therapeutic intervention for physicians to begin referring patients to the pharmacist, even sending complete patient charts and laboratory test results in advance of scheduled patient-pharmacist appointments.

For more than 2 decades, innovative pharmacists have practiced medication- and disease-state management with patients, often in conjunction with medical clinics. Many pharmacists have focused their attention on specific therapeutic areas such as anticoagulation, asthma, diabetes, hyperlipidemia, women's health, or smoking cessation. Numerous studies have been published, with more data accruing daily, illustrating the positive clinical outcomes for patients and the beneficial cost savings for the entire healthcare system when pharmacists are actively engaged in patient care.12-30 Pharmacist intervention outcomes are well documented in the areas of economics, improvement in health-related quality of life, enhanced patient satisfaction, and avoidance of adverse drug effects.31

The expanding roles filled by pharmacists have been created by the mere fact that many physicians may no longer be able to provide the level of patient interactions that they would like to provide. Managed care has forced physicians to see more patients, spending shorter periods of time during each patient encounter. It has been estimated that the average patient-physician interaction is shorter than 7 minutes—hardly sufficient time to address all the disease- and drug-management issues that arise. Through disease-state management programs, pharmacists have consistently demonstrated that it is possible to educate patients about their disease, improve medication use, and take preemptive steps to avoid future complications.

Importantly, in the context of pharmacist-managed drug/disease-state therapeutic programs, pharmacists are knowledgable, easily accessible healthcare professionals capable of delivering care that physicians simply do not have time to provide. Both pharmacists and physicians bring their own unique areas of strengths and expertise to benefit patients. Whether or not Wall and Brown like to admit it, patient outcomes are improving because of pharmacist interventions—a phenomenon that would clearly not occur if the pharmacists' sole responsibility was "technical supervision over dispensation of medication." Rather than acting in a territorial, hostile manner to pharmacists, Wall and Brown should embrace the knowledge and expertise that pharmacists offer.

Pharmacists are making and documenting therapeutic interventions, improving clinical outcomes, and creating a new level of economic savings for the healthcare system at large. Contrary to the allegations made by Wall and Brown, the data speak clearly. Pharmacists have exciting, expanding roles and are certainly not in the business of hijacking the healthcare system. It is important to keep in perspective that nearly 3.3 billion prescriptions are dispensed in outpatient settings every year, which averages roughly 9 million prescriptions per day.32 Of the billions of prescriptions filled annually, only approximately 12 pharmacist "refusals to fill" have been documented during the last decade. Overall, the system appears to be working much more often than it fails.

Healthcare professionals, including pharmacists, should not be forced to participate in activities that they find to be personally objectionable. Safeguards should be established within and among pharmacies and medical clinics to ensure that patients' needs can always be taken care of in a prompt fashion without violating personal beliefs.


    Footnotes
 
See also page 1439.


    References
 Top
 Abstract
 Exercising a Professional Right...
 Pharmacists in Clinical Practice
 References
 

  1. Wall LL, Brown D. Refusals by pharmacists to dispense emergency contraception: a critique. Obstet Gynecol 2006;107:1148-51.[Abstract/Free Full Text]
  2. Durand M, Cravioto MC, Raymond EG, et al. On the mechanism of action of short-term levonorgestrel administration in emergency contraception.Contraception 2001;64:227-34.[CrossRef][Medline]
  3. Trusell J, Raymond EG. Statistical evidence about the mechanism of action of the Yuzpe regimen of emergency contraception. Obstet Gynecol 1999;93:872-6.[Abstract/Free Full Text]
  4. Hapangama D, Glasier AF, Baird DT. The effects of peri-ovulatory administration of levoneorgestrel on the menstrual cycle.Contraception 2001;63:123-9.[CrossRef][Medline]
  5. Marions L, Hultenby K, Lindell I, Sun X, Stabi B, Gemzell Danielsson K. Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstet Gynecol 2002;100:65-71.[Abstract/Free Full Text]
  6. Swahn ML, Westlund P, Johannisson E, Bygdeman M. Effect of postcoital contraceptive methods on the endometrium and the menstrual cycle.Acta Obstet Gynecol Scand 1996;75:738-44.[Medline]
  7. Gemzell-Danielsson K, Marions L. Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception.Hum Reprod Update 2004;10:341-348.[Abstract/Free Full Text]
  8. Croxatto HB, Devoto L, Durand M, et al. Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature. Contraceptrion 2001;63:111-21.
  9. Durand M, Seppala M, Cravioto MC, et al. Late follicular phase administration of levonorgestrel as an emergency contraceptive changes the secretory pattern of glycodelin in serum and endometrium during the luteal phase of the menstrual cycle. Contraception 2005;71:451-7.[CrossRef][Medline]
  10. Academic Health Centers. Leading change in the 21st century. Washington, DC: National Academy Press, 2003.
  11. Kohn LT, Corrigan JM, Donaldson MS. To err is human. Washington, DC: National Academy Press, 2000.
  12. Coast-Senior EA, Droner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics.Ann Pharmacother 1998;32:636-41. DOI10.1345/aph.17095[Abstract]
  13. Cranor CW, Christensen DB. The Ashville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:149-59.
  14. Cranor CW, Bunting BA, Christensen DB. The Ashville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:173-84.[CrossRef]
  15. Garrett DG, Bluml BM. Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc 2005;45:130-7.
  16. Saini B, Krass I, Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother 2004;38:1954-60. Epub 12 Oct 2004. DOI10.1345/aph.1E045[Abstract/Free Full Text]
  17. Barbanel D, Eldridge S, Griffiths C. Can a self-management programme delivered by a community pharmacist improve asthma control? A randomized trial. Thorax 2003;58:851-4.[Abstract/Free Full Text]
  18. McLean W, Gillis J, Waller R. The BC Community Pharmacy Asthma Study: a study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J 2003;10:195-202.[Medline]
  19. Straka RJ, Taheri R, Cooper SL, Smith JC. Achieving cholesterol target in a managed care organization (ACTION) trial.Pharmacotherapy 2005;25:360-71.[CrossRef][Medline]
  20. Till LT, Voris JC, Horst JB. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting. J Manag Care Pharm 2003;9:269-73.[Medline]
  21. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the study of cardiovascular risk intervention by pharmacists (SCRIP).Arch Intern Med 2002;162:1149-55.[Abstract/Free Full Text]
  22. Bozovich M, Ribino CM, Edmunds J. Effects of a clinical pharmacist-management lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals. Pharmacotherapy 2000;20:1375-83.[CrossRef][Medline]
  23. Nola KM, Gourley DR, Portner TS, et al. Clinical and humanistic outcomes of a lipid management program in a community pharmacy setting.J Am Pharm Assoc 2000;40:166-73.
  24. Locke C, Ravnan SL, Patel R, Uchizono JA. Reduction in warfarin adverse events requiring patient hospitalization after implementation of a pharmacist-managed anticoagulation service. Pharmacotherapy 2005;25:685-9.[CrossRef][Medline]
  25. Ernst ME, Brandt KB. Evaluation of 4 years of clinical pharmacist anticoagulation case management in a rural, private physician office. J Am Pharm Assoc 2003;43:630-6.
  26. Wilt VM, Gums JG, Ahmed OI, Moore LM. Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy 1995;15:732-9.[Medline]
  27. Garabedian-Ruffalo SM, Gray DR, Sax MJ, Ruffalo RL. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985;42:304-8.[Abstract]
  28. Berardo DH. Pharmacists' practice opportunities in women's health.Pharm Pract Manag Q 1999;19:42-56.[Medline]
  29. Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev 2004; CD003698.
  30. Bunting BA, Cranor CW. The Ashville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc 2006;46:133-47.
  31. Kaboli PJ, Hoth AB, McClinton BJ, Schnipper JL. Clinical pharmacists and inpatient medical care. Arch Intern Med 2006;166:955-64.[Abstract/Free Full Text]
  32. National Association of Chain Drug Stores. 2004 Community pharmacy results. www.nacds.org/user-assets/pdf_files/2004results.pdf (accessed 2006 Jun 4).

Related articles in The Annals:

Toward Full Professionalization
Alex Berman
The Annals 2006 40: 1439-1440. [PDF]  



This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
K. A. Calis, F. Pucino Jr, S. R Penzak, and F. A Lombardo
Comment: Pharmacist Critique Was Ill-Informed
Ann. Pharmacother., September 1, 2006; 40(9): 1697 - 1698.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
G. G Briggs
Comment: Pharmacist Critique was Ill-Informed
Ann. Pharmacother., July 1, 2006; 40(7): 1474 - 1475.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in The Annals
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karpa, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karpa, K. D.


homecopy help contact us subscription past issues search current issue